Skip to main content
. 2015 Nov 5;2015:1927–1936.

Table 3.

Modularity and detected module classes

Modularity Module1 Module2
M Mi DMi articles covered included articles covered articles covered included articles covered
# %a # %b # %a # %b
ACE Inhibitors 72 2 1 707 27.97% 40 97.56% 796 31.29% 1 2.44%
ADHD 73 3 1 159 18.68% 18 90% 50 5.88% 1 5%
Antihistamines 43 4 3 83 26.77% 9 56.25% 74 23.87% 3 18.75%
Atypical Antipsychotics 83 8 4 187 16.7% 50 34.25% 200 17.86% 45 30.82%
Beta Blockers 89 4 2 400 19.26% 26 61.90% 476 22.97% 12 28.57%
Calcium Channel Blockers 68 5 3 274 22.5% 36 36% 333 27.34% 32 32%
Estrogens 42 6 3 75 20.38% 34 42.5% 66 17.93% 24 30%
NSAIDS 44 3 2 78 19.85% 32 78.05% 42 10.69% 7 17.07%
Opioids 90 3 2 298 15.56% 11 73.33% 592 30.91% 3 20%
Oral Hypoglycemics 31 7 3 161 32.01% 66 48.53% 146 29.03% 33 24.26%
Proton Pump Inhibitors 51 6 2 449 33.68% 37 72.55% 405 30.38% 7 13.73%
Skeletal Muscle Relaxants 322 3 2 826 50.27% 6 66.67% 184 11.20% 2 22.22%
Statins 191 4 2 1384 39.95% 67 78.82% 1160 33.49% 14 16.47%
Triptans 43 2 2 205 30.55% 17 70.83% 183 27.27% 7 29.17%
Urinary Incontinence 57 7 1 67 20.49% 30 75% 18 5.5% 3 7.5%
Antibiotic 25 3 3 45 10.92% 6 60% 125 30.34% 3 30%
Antineoplastic 195 5 3 144 11.13% 9 47.37% 191 14.76% 4 21.05%
Antiretrovirals* 13 1 1 331 44.19% 38 100%
Hearing Loss 87 2 2 116 24.84% 2 66.67% 100 21.41% 1 33.33%
Leukaemia* 92 1 1 80 24.39% 7 100%
Average 86 4 2 303 25.50% 27 67.81% 286 21.78% 11 21.24%

M= number of modules; Mi= number of modules that contain included articles; DMi= number of dominant modules with more than 10% included articles;

*

The SR report has only one module that contains included articles. Therefore, there is no Module2.

a

= percentage of articles covered in the module;

b

= percentage of included articles covered in the module